Clinical Trial Update: Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with oligo-metastatic/persistent/recurrent ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Gemelli Molise Hospital | Conditions: Ovarian Neoplasms, Recurrent Ovarian Carcinoma | NA | Status: COMPLETED